Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion.
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
We recently demonstrated that sc administered interleukin-6 (IL-6) strongly stimulates the human hypothalamic-pituitary-adrenal (HPA) axis, with mild toxicity and no hypotensive effects. In this study, we evaluated the response of the human HPA axis to escalating iv doses of recombinant IL-6 in six patients with cancer and good performance status who received daily, every 8 h, three equal doses of 0.3-30 micrograms/kg IL-6. The plasma levels of IL-6 assayed by a specific enzyme-linked immunosorbent assay during the 4 h following the first IL-6 injection were elevated for 2-4 h, proportionally to the amount of injected IL-6. Administration of the cytokine was followed by marked elevations of plasma ACTH (53.0-98.6 pmol/L) and cortisol (824.9-1729.9 nmol/L) independently of the IL-6 dose administered, suggesting that the doses employed were at the top of the dose-response curve for these hormones. Interestingly, plasma arginine vasopressin (AVP) levels were also elevated during the 2 h after IL-6 injection in all patients who received a dose of 3 micrograms/kg or more, suggesting that IL-6 activated the magnocellular AVP-secreting neurons and that it might be involved in the syndrome of inappropriate AVP secretion. Cortisol elevations with peaks similar to those observed after the first injection of IL-6 were also detected in plasma sampled every 2 h after the second and third injections, suggesting that there was no rapid tachyphylaxis in response to IL-6 administration. Plasm…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor
Sapolsky, R., Rivier, C., Yamamoto, G., Plotsky, P., & Vale, W. (1987) · Science · doi:10.1126/science.2821621 · Cited by 1,504
Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF)
Akira, S., Hirano, T., Taga, T., & Kishimoto, T. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.11.2199284 · Cited by 1,306
Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans.
Mastorakos, G., Chrousos, G. P., & Weber, J. S. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.8263159 · Cited by 591
Self-citationAcute Hypothalamic–Pituitary–Adrenal Responses to the Stress of Treadmill Exercise
Luger, A., Deuster, P. A., Kyle, S. B., Gallucci, W. T., Montgomery, L. C., Gold, P. W., Loriaux, D. L., & Chrousos, G. P. (1987) · New England Journal of Medicine · doi:10.1056/nejm198705213162105 · Cited by 516
Self-citationInterleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets.
Kasahara, T., Hooks, J. J., Dougherty, S. F., & Oppenheim, J. J. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.4.1784 · Cited by 479
Naitoh, Y., Fukata, J., Tominaga, T., Nakai, Y., Tamai, S., Mori, K., & Imura, H. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81305-6 · Cited by 421
Perlstein, R. S., Whitnall, M. H., Abrams, J. S., Mougey, E. H., & Neta, R. (1993) · Endocrinology · doi:10.1210/en.132.3.946 · Cited by 257
BERNARDINI, R., KAMILARIS, T. C., CALOGERO, A. E., JOHNSON, E. O., GOMEZ, M. T., GOLD, P. W., & CHROUSOS, G. P. (1990) · Endocrinology · doi:10.1210/endo-126-6-2876 · Cited by 232
Self-citationPhase I trial of subcutaneous interleukin-6 in patients with advanced malignancies.
Weber, J., Yang, J. C., Topalian, S. L., Parkinson, D. R., Schwartzentruber, D. S., Ettinghausen, S. E., Gunn, H., Mixon, A., Kim, H., & Cole, D. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.499 · Cited by 216
Self-citationSCHÜRMEYER, T. H., AVGERINOS, P. C., GOLD, P. W., GALLUCCI, W. T., TOMAI, T. P., CUTLER, G. B., LORIAUX, D. L., & CHROUSOS, G. P. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-6-1103 · Cited by 206
Self-citation
Cited by
Items 101–200 of 272
Hyponatraemia in imported malaria is common and associated with disease severity
van Wolfswinkel, M. E., Hesselink, D. A., Zietse, R., Hoorn, E. J., & van Genderen, P. J. J. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-140 · Cited by 30
Modulation of Body Temperature, Interleukin-6 and Leptin by Oral Contraceptive Use
Salkeld, B. D., MacAulay, J. C., Ball, R. W., & Cannon, J. G. (2001) · Neuroimmunomodulation · doi:10.1159/000059389 · Cited by 31
Mastorakos, G. P., & Ilias, Ι. (2000) · Zeitschrift für Rheumatologie · doi:10.1007/s003930070023 · Cited by 33
Self-citationARASHIMA, Y., Kato, K., Komiya, T., Kumasaka, K., Matsukawa, Y., Murakami, M., Takahashi, K., Ikeda, T., & Arakawa, Y. (2004) · Internal Medicine · doi:10.2169/internalmedicine.43.49 · Cited by 37
Hormone responses to stress in patients with major burns
Murton, S. A., Tan, S. T., Prickett, T. C. R., FRAMPTON, C. M. A., & Donald, R. A. (1998) · British Journal of Plastic Surgery · doi:10.1054/bjps.1997.0147 · Cited by 34
Does inflammation link stress to poor COVID‐19 outcome?
Lamontagne, S. J., Pizzagalli, D. A., & Olmstead, M. C. (2020) · Stress and Health · doi:10.1002/smi.3017 · Cited by 31
Kawashima, A., Tsujimura, A., Takayama, H., et al. (2012) · International Journal of Urology · doi:10.1111/j.1442-2042.2012.03115.x · Cited by 29
Hyponatremia in the intensive care unit: How to avoid a Zugzwang situation?
Rafat, C., Flamant, M., Gaudry, S., Vidal‐Petiot, E., Ricard, J.-D., & Dreyfuss, D. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0066-8 · Cited by 40
Krismer, A. C., nser, M. W. D., Lindner, K. H., Stadlbauer, K., Mayr, V. D., Lienhart, H. G., Arntz, R., & Wenzel, V. (2006) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200606010-00005 · Cited by 37
Leukemia Inhibitory Factor Regulates Proopiomelanocortin Transcriptiona
Ray, D. W., Ren, S.-G., & Melmed, S. K. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09560.x · Cited by 30
Siegel, A. J. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.03.031 · Cited by 28
Adenosine signalling pathways in the pituitary gland: one ligand, multiple receptors
Rees, A., Scanlon, M., & Ham, J. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1770357 · Cited by 30
Critical role of rabphilin‐3A in the pathophysiology of experimental lymphocytic neurohypophysitis
Yasuda, Y., Iwama, S., Kiyota, A., Izumida, H., Nakashima, K., Iwata, N., Ito, Y., Morishita, Y., Goto, M., Suga, H., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5046 · Cited by 31
“Inflammatory cytokines, including interleukin (IL)-1β, tumour necrosis factor-α, and IL-6, can affect AVP secretion [34,35].”
BackgroundMainardi, G. L., Saleri, R., Tamanini, C., & Baratta, M. (2002) · Hormone Research in Paediatrics · doi:10.1159/000065487 · Cited by 27
Kalkman, H. O. (2019) · Pharmaceuticals · doi:10.3390/ph12030113 · Cited by 34
“This is consistent with data in humans that IL-6 activates the HPA axis [132].”
ResultReproductive placental corticotropin-releasing hormone and its clinical implications
Chrousos, G. P. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70710-6 · Cited by 26
Self-citationThe emerging role of peripheral corticotropin-releasing hormone (CRH)
Ilias, I., & Mastorakos, G. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345186 · Cited by 24
Self-citationFitness alters fluid regulatory but not behavioural responses to hypohydrated exercise
Merry, T. L., Ainslie, P. N., Walker, R. J., & Cotter, J. D. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2008.06.015 · Cited by 25
Update on the role of ovarian corticotropin‐releasing hormone
Kiapekou, E., Zapanti, E. D., Mastorakos, G. P., & Loutradis, D. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05685.x · Cited by 28
Self-citationChrist‐Crain, M., Hoorn, E. J., Sherlock, M., Thompson, C. J., & Wass, J. A. H. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0596 · Cited by 27
Hyponatremia and Oxidative Stress
Fibbi, B., Marroncini, G., Anceschi, C., Naldi, L., & Peri, A. (2021) · Antioxidants · doi:10.3390/antiox10111768 · Cited by 29
Oliveira‐Pelegrin, G. R., Basso, P. J., Soares, A. S., Martinez, M. R., Riester, K., & Rocha, M. J. A. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.02.007 · Cited by 25
Hough, D., Swart, P., & Cloete, S. W. P. (2013) · Animals · doi:10.3390/ani3020442 · Cited by 26
Age-impaired fluid homeostasis depends on the balance of IL-6/IGF-I in the rat supraoptic nuclei
Palin, K., Moreau, M. L., Orcel, H., Duvoid, A., Rabié, A., KELLEY, K. W., & Moos, F. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.12.006 · Cited by 28
Sharman, G., Ghorbel, M. T., Leroux, M., Beaucourt, S. M., Wong, L., & Murphy, D. (2004) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2003.11.005 · Cited by 23
Michl, Beikler, Engelhardt, & Weber (2000) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2000.00423.x · Cited by 25
SIADH in Systemic JIA Resolving After Treatment With an IL-6 Inhibitor
Hodax, J. K., Bialo, S. R., & Yalçindağ, A. (2017) · PEDIATRICS · doi:10.1542/peds.2016-4174 · Cited by 23
Hormonal Disturbances in Visceral Leishmaniasis (Kala-Azar)
Verde, F. A. L., Verde, F. A. A. L., Neto, A. S., et al. (2011) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2011.09-0171 · Cited by 23
Saito, J., Ozaki, Y., Ohnishi, H., Nakamura, T., & Ueta, Y. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00129-3 · Cited by 23
Helwig, B. G., Musch, T. I., Craig, R. A., & Kenney, M. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00507.2006 · Cited by 22
“Furthermore, IL-6 stimulation of PVN magnocellular neurons results in release of arginine vasopressin, a secretagogue that is also a well-defined activator of the HPA axis (40).”
BackgroundSmiley, C. E., & Wood, S. K. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108212 · Cited by 25
Exercise-Associated Hyponatremia
Schucany, W. G. (2007) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2007.11928331 · Cited by 22
Niwa, F., Kawai, M., Kanazawa, H., Iwanaga, K., Matsukura, T., Shibata, M., Hasegawa, T., & Heike, T. (2013) · Clinical Endocrinology · doi:10.1111/cen.12049 · Cited by 23
Elevated Circulating Leukemia Inhibitory Factor in Patients With Extensive Burns
Akita, S., Akino, K., Ren, S. G., Melmed, S. K., Imaizumi, T., & Hirano, A. (2006) · Journal of Burn Care & Research · doi:10.1097/01.bcr.0000197679.08671.a5 · Cited by 22
“nal transduction occurs via the gp130 and STAT pathways in the HPA axis.(28,29) Because there was a”
BackgroundEdmonds, Z. V. (2012) · Journal of Hospital Medicine · doi:10.1002/jhm.1933 · Cited by 22
Marar, I. E., & Amico, J. A. (1998) · Endocrine · doi:10.1385/endo:8:1:13 · Cited by 22
Novel insights into how purines regulate pituitary cell function
Rees, A., Scanlon, M. F., & Ham, J. (2003) · Clinical Science · doi:10.1042/cs20030053 · Cited by 23
Dixon, B. N., Daley, R. J., Buie, L. W., Hsu, M., Park, J. H., Brentjens, R. J., Purdon, T. J., & Latcha, S. (2019) · Clinical Nephrology · doi:10.5414/cn109872 · Cited by 23
“Animal and human studies have demonstrated that interleukin-6 (IL-6) activates the central magnocellular arginine vasopressin (AVP)-secreting neurons in the brain to produce non-osmotic, non-volume-mediated increases in AVP levels [1, 2, 3].”
BackgroundHyponatremia in patients with systemic lupus erythematosus
Shin, J. I., Park, S. J., Suh, C., Lee, K. H., Hur, M. W., Han, S. Y., Kim, D. S., & Kim, J. H. (2016) · Scientific Reports · doi:10.1038/srep25566 · Cited by 21
Gene Regulation System of Vasopressin and Corticotoropin-Releasing Hormone
Yoshida, M. (2008) · Gene Regulation and Systems Biology · doi:10.4137/grsb.s424 · Cited by 25
“In humans, plasma vasopressin levels are elevated 2h after IL-6 injection (Mastorakos et al. 1994).”
Hyponatremia in a Patient with Chronic Inflammatory Disease.
Murakami, T., Matoba, H., Kuga, Y., et al. (1998) · Internal Medicine · doi:10.2169/internalmedicine.37.792 · Cited by 20
Grinevich, V., Ma, X., Verbalis, J. G., & Aguilera, G. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7784 · Cited by 20
Hyponatremia and Cancer: From Bedside to Benchside
Fibbi, B., Marroncini, G., Naldi, L., Anceschi, C., Errico, A., Norello, D., & Peri, A. (2023) · Cancers · doi:10.3390/cancers15041197 · Cited by 23
Kanikowska, D., Sugenoya, J., Sato, M., Shimizu, Y., Inukai, Y., Nishimura, N., & Iwase, S. (2009) · International Journal of Biometeorology · doi:10.1007/s00484-009-0236-1 · Cited by 22
“Il-6 is a strong activator of the hypothalamic-pituitaryadrenal axis (HPA) (Mastorakos et al. 1994).”
BackgroundHypothalamic-Pituitary-Adrenal Axis in Rheumatoid Arthritis
Imrich, R., & Rovenský, J. (2010) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2010.09.003 · Cited by 22
“Conversely, in a controlled environment, administration of systemic mediators of inflammation was found to trigger acute HPA response.(1) Whether the chronic elevation of inflammatory cytokine in patients with inflammatory diseases”
BackgroundSyndrome of inappropriate anti‐diuretic hormone in Kawasaki disease
Mori, J., Miura, M., Shiro, H., et al. (2010) · Pediatrics International · doi:10.1111/j.1442-200x.2010.03264.x · Cited by 19
Kawasaki disease and hyponatremia
Shin, J. I., Kim, J. H., Lee, J. S., et al. (2006) · Pediatric Nephrology · doi:10.1007/s00467-006-0242-z · Cited by 19
“Although the exact mechanism for the development of hyponatremia in KD remains unknown, the relationship between interleukin (IL)-6 or IL-1 beta and ADH secretion has been suggested [3, 4].”
Fernández-Celemı́n, L., & Thissen, J. (2001) · Endocrinology · doi:10.1210/endo.142.1.7903 · Cited by 18
Kawakami, M., He, J., Sakamoto, T., et al. (2001) · Critical Care Medicine · doi:10.1097/00003246-200104000-00023 · Cited by 18
Strickland, J., McIlmoil, S. A., Williams, B. J., Seager, D. C., Porter, J. P., & Judd, A. M. (2017) · Steroids · doi:10.1016/j.steroids.2016.12.014 · Cited by 20
“Thus, IL-6 may directly stimulate the adrenal cortex to release cortisol and/or increase the sensitivity of the adrenal cortex to ACTH [2,3,6,12,19].”
InfluentialAnticancer Medications and Sodium Dysmetabolism
Krishnamurthy, A., Bhattacharya, S., Lathia, T. B., Kantroo, V., Kalra, S., & Dutta, D. (2020) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2020.16.2.122 · Cited by 23
“There are isolated case reports of SIADH induced by these agents, presumably via a stimulatory effect on ADH secretion.(113,114) Their clinical relevance is minimal, due to their limited use in routine cancer treatment.”
BackgroundMonnerat, S., Christ‐Crain, M., & Refardt, J. C. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01138-4 · Cited by 26
“In addition, direct pharmacological inhibition of the urea transporter 173 and IL-6 antagonism for SIAD secondary to inflammation 174,175 could represent a currently unexploited treatment strategy.”
COVID-19 Pneumonia: An Emerging Cause of Syndrome of Inappropriate Antidiuretic Hormone
Sheikh, M. M., Ahmad, E., Jeelani, H. M., Riaz, A., & Muneeb, A. (2020) · Cureus · doi:10.7759/cureus.8841 · Cited by 17
Unexplained Hyponatremia: Seek and You Will Find
Hoorn, E. J., Hotho, D. M., Hassing, R. J., & Zietse, R. (2011) · Nephron Physiology · doi:10.1159/000322240 · Cited by 19
“]. For example, the intravenous administration of recombinant interleukin-6 to healthy volunteers shows a rapid and dose-dependent rise in plasma vasopressin concentrations [”
BackgroundRaab, C., Weidmann, E., Schmidt, A., Bergmann, L., Badenhoop, K. W. J., Usadel, K. H., & Haak, T. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00592.x · Cited by 17
Symptomatic Hypotonic Hyponatremia Presenting at High Altitude
Spano, S. J., Reagle, Z., & Evans, T. (2014) · Wilderness & Environmental Medicine · doi:10.1016/j.wem.2013.09.014 · Cited by 15
“increased levels of antidiuretic hormone, also known as arginine vasopressin in this population.(21) A diagnosis of SIADH should only be made when normal adrenal and renal function is confirmed in a patient who presents with normovolemic hypoosmolar hyponatremia.”
BackgroundEvaluation of Endocrine Function
Guber, H. A., & Farag, A. F. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0974-2.00024-5 · Cited by 19
The association between work stress and inflammatory biomarkers in J ordanian male workers
Almadi, T., Cathers, I., Hamdan‐Mansour, A. M., & Chow, C. M. (2011) · Psychophysiology · doi:10.1111/j.1469-8986.2011.01296.x · Cited by 16
Hyponatremia in children with pneumonia rarely means SIADH
Tagarro, A., Martín, M.-D., Del-Amo, N., et al. (2018) · Paediatrics & Child Health · doi:10.1093/pch/pxy003 · Cited by 14
“ADH has been shown to be released after injection of lipopolysaccharides, IL-1B and IL-6 (12) (13) (14) .”
BackgroundPulmonary Edema in Healthy Subjects in Extreme Conditions
Garbella, E., Catapano, G. A., Pratali, L., et al. (2011) · Pulmonary Medicine · doi:10.1155/2011/275857 · Cited by 14
“Further a nonosmotic stimulation of arginine vasopressin is the enhanced release of muscle-derived interleukin (IL) 6 during glycogen depletion, as documented by administration of recombinant IL-6 in healthy subjects [37].”
BackgroundAre CRH & NGF as psychoneuroimmune regulators in women with polycystic ovary syndrome?
Zangeneh, F. Z., Naghizadeh, M. M., Bagheri, M., & Jafarabadi, M. N. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1250152 · Cited by 17
Qi, Z., Pang, Y., Lin, L., Zhang, B., Shao, J., Liu, X., & Zhang, X. (2018) · Medical Science Monitor · doi:10.12659/msm.909733 · Cited by 22
“Thus, our findings suggest that the effect of acupuncture plus hydrotherapy can improve of the endothelial cells’ anti-inflammatory property, reduction of free radicals, and regulate the hypothalamic-pituitary-adrenal axis function [49,50].”
Backgroundgp130-Related Cytokines and Their Receptors in the Pituitary
Melmed, S. K. (1997) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(97)00156-2 · Cited by 14
Vai, B., Palladini, M., Lorenzi, C., Zanardi, R., Poletti, S., Aggio, V., & Benedetti, F. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100522 · Cited by 17
Lyme neuroborreliosis presenting as the syndrome of inappropriate antidiuretic hormone secretion.
Perkins, M., Shumway, N. M., & Jackson, W. L. (2006) · PubMed · Cited by 13
Corticotropin-releasing hormone inhibits in vitro oocyte maturation in mice
Kiapekou, E., Zapanti, E. D., Voukelatou, D., Mavreli, T., Stefanidis, K., Drakakis, P., Mastorakos, G. P., & Loutradis, D. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.12.023 · Cited by 15
Self-citationTicks and salt: an atypical case of neuroborreliosis
Siddiqui, N., Peter, D. M. S., & Marur, S. (2017) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.1080/20009666.2017.1407209 · Cited by 13
“A very small study done in 1994 including six patients with cancer showed that two hours after injection with IL-6, plasma ADH rose in all patients suggesting that this inflammatory cytokine may directly cause SIADH [15].”
BackgroundA Systematic Review of Sodium Disorders in HHV-6 Encephalitis
Victoria, N. C., Phan, T. L., & Agarwal, K. A. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2020.01.023 · Cited by 14
Kovács, K. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)39013-7 · Cited by 18
Furukawa, J., Miyake, H., Kusuda, Y., et al. (2014) · International Journal of Clinical Oncology · doi:10.1007/s10147-014-0713-3 · Cited by 12
Atila, C., Monnerat, S., Bingisser, R. M., et al. (2022) · Endocrine Connections · doi:10.1530/ec-22-0171 · Cited by 12
Onishi, C., Ikejiri, F., Kawakami, K., et al. (2011) · Annals of Hematology · doi:10.1007/s00277-011-1196-1 · Cited by 12
“One report states that IL-6 is coexpressed with magnocellular arginine vasopressin (AVP=ADH) in the supraoptic and paraventricular nuclei neurons [28], while another suggests that IL-6 activates the magnocellular AVP-secreting neurons, inducing AVP secretion in the hypothalamus [14, 15].”
BackgroundFasting Differentially Modulates the Immunological System: Its Mechanism and Sex Difference
Hiramoto, K., Homma, T., Jikumaru, M., Miyashita, H., Sato, E. F., & Inoue, M. (2008) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.2008049 · Cited by 15
“The study protocol ran for 3 days and included the following groups, normal fed, 24, 48, and 72 h of fasting.”
MethodYoshimura, R., Katsuki, A., Atake, K., Hori, H., Igata, R., & Konishi, Y. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s123121 · Cited by 15
Cytokine activation of the hypothalamo–pituitary–adrenal axis
Dunn, A. J. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80054-9 · Cited by 17
The Syndrome of Inappropriate Secretion of Anti-Diuretic Hormone (SIADH) and Brucellosis
Bala, K. A., Doğan, M., Kaba, S., et al. (2016) · Medical Science Monitor · doi:10.12659/msm.899977 · Cited by 11
“, pneumonia, malaria), suggesting non-osmotic ADH secretion [18,19].”
Hyponatremia as an Inflammatory Marker of Lupus Activity Is a Fact or Fad: A Cross-Sectional Study
Ali, A. Y., Behiry, M. E., & Ahmed, S. A. A. (2020) · Open Access Rheumatology Research and Reviews · doi:10.2147/oarrr.s237168 · Cited by 13
Dykstra, K. H., Rogge, H., Stone, A., Loewy, J. W., Keith, J. C., & Schwertschlag, U. S. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/00912700022009521 · Cited by 11
Hyponatremia in visceral leishmaniasis
Verde, F. A. L., Verde, F. A. A. L., Veronese, F. J. V., et al. (2010) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652010000500006 · Cited by 10
Hyponatraemia in imported malaria: the pathophysiological role of vasopressin
Hoorn, E. J., van Wolfswinkel, M. E., Hesselink, D. A., de Rijke, Y. B., Koelewijn, R., van Hellemond, J. J., & van Genderen, P. J. J. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-26 · Cited by 14
“Of potential relevance, in this regard, is the observation that the pro-inflammatory cytokine interleukin-6 is elevated in malaria and also implicated in the non-osmotic release of AVP [21,22].”
BackgroundHolland-Bill, L., Christiansen, C. F., Farkas, D. K., et al. (2017) · Acta Oncologica · doi:10.1080/0284186x.2017.1378430 · Cited by 10
“Not only the proneness to induce SIADH, but also different predisposition of each cancer type to stimulate an inflammatory response and thereby hyponatremia, could explain the difference in risk observed [14,15].”
ResultStress and Critical Illness: The Integrated Immune/Hypothalamic-Pituitary-Adrenal Axis Response
Torpy, D. J., & Chrousos, G. P. (1997) · Journal of Intensive Care Medicine · doi:10.1177/088506669701200503 · Cited by 12
Self-citationAssay of AVP, CRP, and LPS in leukemia
Han, D., Zhang, Y., Bai, Q., & CHEN, X. Q. (2007) · International Journal of Laboratory Hematology · doi:10.1111/j.1751-553x.2006.00839.x · Cited by 11
Suzuki, Y., Kobayashi, R., Iguchi, A., et al. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.247 · Cited by 9
Influenza as a Cause of SIADH Related Hyponatremia: A Case Report
Gaglani, B. (2017) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2017/25785.9797 · Cited by 9
Adrenocortical Response and Cortisone Replacement in Systemic Inflammatory Response Syndrome
Ihle, B. U. (2001) · Anaesthesia and Intensive Care · doi:10.1177/0310057x0102900210 · Cited by 13
Atila, C., Chifu, I. O., Drummond, J., Vogt, D., Nahum, U., Faßnacht, M., Winzeler, B. F., Refardt, J. C., & Christ‐Crain, M. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00053-1 · Cited by 13
Kamoi, K. (2008) · International Journal of General Medicine · doi:10.2147/ijgm.s2595 · Cited by 8
“Although such hyponatremia may be caused by increased interleukin-1 β or -6 levels (Mastorakos et al 1994; Chubachi et al 1995), blood levels of these cytokines were not elevated in the present patient.”
Electrolytes Abnormalities in Cancer Patients
Rashidi, A., Youssef, N., Workeneh, B., Carsel, A., Gutgarts, V., & Latcha, S. (2025) · American Journal of Nephrology · doi:10.1159/000544877 · Cited by 7
“Various studies have demonstrated that IL-6 activates the central magnocellular arginine vasopressin (AVP)-secreting neurons in the brain to produce non-osmotic, non-volume-mediated increases in AVP [17 – 19].”
Down with the flu: Hyponatremia in a patient with influenza
Poudel, D. R., Karmacharya, P., Pathak, R., et al. (2015) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.157488 · Cited by 7
Mastorakos, G. P., Cizza, G., Květňanský, R., Bergamini, E., Blackman, M. R., Gold, P. W., & Chrousos, G. P. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00042-5 · Cited by 7
Self-citationZhu, C.-G., Zhang, Q.-Z., Zhu, M. J., Zhai, Q.-L., Liang, X.-Y., Shao, Z.-H., Hoeve, E. V., & Qu, H. (2013) · BMC Endocrine Disorders · doi:10.1186/1472-6823-13-19 · Cited by 7
“Some cytokines, such as interleukin (IL)-2, IL-6, IL-1β, and tumor necrosis factor (TNF)-α, have been reported to stimulate parvicellular and magnocellular neurons to secrete more ADH thus causing SIADH [18,19].”
BackgroundInoue, M., Nakai, K., Tanaka, S., Mitsuiki, K., Tokumoto, M., Tsuruya, K., Kitazono, T., & Nakano, T. (2023) · Clinical and Experimental Nephrology · doi:10.1007/s10157-023-02395-1 · Cited by 7
Morimoto, K., Ogihara, T., Shiomi, T., et al. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.0252 · Cited by 7
“For instance, there is evidence that intravenous administration of IL-6 triggers secretion of ADH (13).”
BackgroundKawasaki Disease and Hyponatremia
Kil, H. R. (2010) · Korean Circulation Journal · doi:10.4070/kcj.2010.40.10.489 · Cited by 7
Paraneoplastic neurological syndromes of small cell lung cancer
Barahman, M., Shamsaei, G., Kashipazha, D., et al. (2024) · Postępy Psychiatrii i Neurologii · doi:10.5114/ppn.2024.141157 · Cited by 6
“An alternative hypothesis suggests that the release of pituitary AVP may be stimulated by hypoxia and inflammatory cytokines, such as interleukin-6, produced during pulmonary infections [15].”
BackgroundThe role of the stress adaptive response in multiple sclerosis
Zapanti, E. D., Dermentzoglou, A., Kazakou, P., Kilindireas, K., & Mastorakos, G. P. (2025) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2025.101204 · Cited by 7
Self-citationRecurrent Severe Hyponatremia in a Patient with Sjögren's Syndrome
Kim, H. D., Lee, J. J., Chung, B. H., et al. (2020) · Electrolytes & Blood Pressure · doi:10.5049/ebp.2020.18.1.19 · Cited by 6
Nobbenhuis, R., Refardt, J. C., Vogt, D., et al. (2021) · Biomarkers · doi:10.1080/1354750x.2021.1970808 · Cited by 6
Associations of Dysnatremia with COVID-19 Status and Mortality
Liu, D., Mowrey, W. B., Fisher, M. C., Basalely, A. M., McCarthy, J., Kumar, N., Thakkar, J., Azzi, Y., Brogan, M. E., Golestaneh, L., et al. (2022) · Kidney360 · doi:10.34067/kid.0001062022 · Cited by 6
“The authors speculated that this relationship could be mediated by IL-6 stimulated vasopressin release (21).”
Background
Metadata
- Authors
- Mastorakos, G., Weber, J. S., Magiakou, M. A., Gunn, H., & Chrousos, G. P.
- Affiliations
- National Institutes of Health (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1994-10
- Volume
- 79
- Issue
- 4
- Pages
- 934-939
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2068437805
- Cited by
- 290
- References
- 28
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 6 · 2023: 11 · 2022: 14 · 2021: 9 · 2020: 12 · 2019: 6 · 2018: 12 · 2017: 12 · 2016: 8 · 2015: 6 · 2014: 5 · 2013: 6 · 2012: 8
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- interleukin-6, hypothalamic-pituitary-adrenal axis, syndrome of inappropriate antidiuretic hormone secretion, ACTH, cortisol, magnocellular neurons, cytokine induction, tachyphylaxis, IL-1β, TNF-α, cancer patients, provocation tests, dose-response curves
- MeSH terms
- Adrenocorticotropic Hormone, Adult, Arginine Vasopressin, Circadian Rhythm, Corticotropin-Releasing Hormone, Female, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Inappropriate ADH Syndrome, Male, Middle Aged, Recombinant Proteins, Interleukin-6, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.